公开(公告)号：US20240358511A1

公开(公告)日：2024-10-31

申请号：US18767778

申请日：2024-07-09

申请人： EDWARDS LIFESCIENCES CORPORATION

发明人： David Maimon ,  Liron Tayeb ,  Eran Goldberg

IPC分类号： A61F2/24 ,  A61F2/95 ,  A61M25/00

CPC分类号： A61F2/2439 ,  A61F2/2427 ,  A61F2/2433 ,  A61M25/0023 ,  A61F2/9517 ,  A61M2025/0024

摘要： The active introducer sheath systems disclosed herein are expanded by activating a translation mechanism at the handle. The sheath has an inner cylindrical structure of comingled fixed and mobile elongate rods bound together by an attachment line. Activating the translation mechanism causes the mobile rods to move axially with respect to the fixed rods, changing the internal tension in the attachment line. Increased tension draws the fixed and mobile rods closer together, decreasing the diameter of the cylindrical structure. Decreased tension in the attachment line enables the fixed and mobile rods to move apart, increasing the diameter of the cylindrical structure. A prosthetic device, such as a prosthetic heart valve, can be routed through the expanded sheath and to the implantation site. During implantation, the sheath can be contracted back to its original outer diameter, and expanded again for retrieval of the delivery apparatus.

公开(公告)号：US20240350287A1

公开(公告)日：2024-10-24

申请号：US18750859

申请日：2024-06-21

申请人： Covidien LP

发明人： Aaron L. Berez ,  Quang Q. Tran

IPC分类号： A61F2/90 ,  A61B17/00 ,  A61B17/12 ,  A61B17/22 ,  A61F2/01 ,  A61F2/06 ,  A61F2/07 ,  A61F2/82 ,  A61F2/844 ,  A61F2/852 ,  A61F2/86 ,  A61F2/915 ,  A61F2/95 ,  A61F2/958 ,  A61F2/966

CPC分类号： A61F2/90 ,  A61B17/12 ,  A61B17/12022 ,  A61B17/12109 ,  A61B17/12118 ,  A61B17/12168 ,  A61F2/013 ,  A61F2/06 ,  A61F2/82 ,  A61F2/844 ,  A61F2/86 ,  A61F2/915 ,  A61F2/95 ,  A61F2/966 ,  A61F2/9661 ,  A61F2/9662 ,  A61B2017/00867 ,  A61B2017/1205 ,  A61B2017/12054 ,  A61B2017/22001 ,  A61F2/01 ,  A61F2002/016 ,  A61F2002/018 ,  A61F2/07 ,  A61F2002/823 ,  A61F2002/826 ,  A61F2/852 ,  A61F2002/91558 ,  A61F2002/9505 ,  A61F2/9522 ,  A61F2002/9528 ,  A61F2002/9534 ,  A61F2/958 ,  A61F2002/9665 ,  A61F2230/001 ,  A61F2230/0069 ,  A61F2230/0078 ,  A61F2230/008 ,  A61F2230/0091 ,  A61F2230/0095 ,  A61F2250/0015 ,  A61F2250/0063

摘要： Described herein are flexible implantable occluding devices that can, for example, navigate the tortuous vessels of the neurovasculature. The occluding devices can also conform to the shape of the tortuous vessels of the vasculature. In some embodiments, the occluding devices can direct blood flow within a vessel away from an aneurysm or limit blood flow to the aneurysm. Some embodiments describe methods and apparatus for adjusting, along a length of the device, the porosity of the occluding device. In some embodiments, the occluding devices allows adequate blood flow to be provided to adjacent structures such that those structures, whether they are branch vessels or oxygen-demanding tissues, are not deprived of the necessary blood flow.

公开(公告)号：US20240325179A1

公开(公告)日：2024-10-03

申请号：US18741192

申请日：2024-06-12

申请人： Bolton Medical, Inc.

发明人： Bryan Vancheri

IPC分类号： A61F2/95

CPC分类号： A61F2/9522

摘要： A stent graft crimping device for radially constricting a stent graft includes a rigid cylinder defining a slot extending parallel to a longitudinal axis of a flexible sheet having a straight edge and a second edge and extending within the rigid cylinder to define a pocket. In a method of use, a stent graft can be positioned within the pocket and radially constricted by pulling on the second edge of the flexible sheet while the straight edge, having a raised component, remains at the slot defined by the rigid cylinder. The stent graft crimping device can be employed independently or as a system in combination with components of a stent graft delivery device.

公开(公告)号：US20240315841A1

公开(公告)日：2024-09-26

申请号：US18678856

申请日：2024-05-30

申请人： Cephea Valve Technologies, Inc.

发明人： Randolf von Oepen ,  Hugo A. Cobar ,  Francisco Valencia ,  Russell Patrick Shelton ,  Henry Thek Chan ,  Evelyn N. Haynes ,  Kim Lela Hayenga ,  Curtis James Caton ,  Gregory Matthew Hyde ,  Austin Michael Sherman ,  Gabriel H. Monteon

IPC分类号： A61F2/24 ,  A61F2/95 ,  A61L2/00 ,  A61M5/14 ,  A61M25/00

CPC分类号： A61F2/2433 ,  A61F2/2436 ,  A61F2/9524 ,  A61F2250/0098 ,  A61L2/0094 ,  A61M2005/1403 ,  A61M2025/0019

摘要： The present disclosure describes devices, systems, and methods for intravascularly delivering an implantable device to a targeted anatomical site such as the mitral annulus. A delivery system includes a delivery member coupled to a handle assembly and extending distally from the handle assembly. A delivery catheter is concentrically positioned within an outer member and configured to advance the intravascular device relative to the outer member. The delivery catheter includes a distal can structure configured to house at least a portion of the intravascular device in a compressed, pre-deployed position.

公开(公告)号：US12083029B2

公开(公告)日：2024-09-10

申请号：US17536834

申请日：2021-11-29

申请人： Boston Scientific Scimed, Inc.

发明人： Kimberly DeGraaf ,  Timothy P. Harrah ,  Mark W. Boden ,  Jan Seppala

IPC分类号： A61F2/88 ,  A61F2/04 ,  A61F2/91 ,  A61M27/00 ,  A61B17/00 ,  A61F2/95

CPC分类号： A61F2/91 ,  A61F2/042 ,  A61F2/88 ,  A61F2/885 ,  A61B2017/003 ,  A61F2002/9511 ,  A61M27/008

摘要： The present disclosure relates generally to controlled extension medical stents, and more particularly to controlled extension devices positioned in the body to stent the ureter and facilitate drainage from the kidney to the bladder.

公开(公告)号：US12082845B2

公开(公告)日：2024-09-10

申请号：US18162036

申请日：2023-01-31

申请人： The Trustees of the University of Pennsylvania ,  The Children's Hospital of Philadelphia ,  Onocor LLC

发明人： Matthew J Gillespie ,  Joseph H Gorman, III ,  Robert C Gorman ,  Mark Piper

IPC分类号： A61B17/50 ,  A61B17/00 ,  A61B17/22 ,  A61B17/221 ,  A61F2/24 ,  A61F2/95 ,  A61F2/962

CPC分类号： A61B17/50 ,  A61B17/22031 ,  A61B17/221 ,  A61F2/962 ,  A61B2017/00367 ,  A61B2017/00778 ,  A61B2017/22034 ,  A61B2017/22035 ,  A61B2017/2215 ,  A61F2/2427 ,  A61F2002/9528 ,  A61F2002/9623

摘要： Disclosed are systems, methods, and devices for percutaneous retrieval of objects, such as endovascular devices, from an internal body space. The present inventions have vascular, non-vascular (gastrointestinal), and surgical (laproscopic) applications. The inventions include a a wire woven distal end that is formed from wires and includes a substantially cylindrical main body section comprising a leading end, a trailing end, and a middle portion extending between the leading end and the trailing end and defining a longitudinal axis of the main body section, and a flare defining a mouth of the wire woven distal end that projects circumferentially from the leading end of the main body section, wherein when at least a portion of the retrieval end is transitioned to a compressed state following capture of an object, the retrieval end exerts an inward force that at least partially collapses or compresses the object.

公开(公告)号：US20240293243A1

公开(公告)日：2024-09-05

申请号：US18661573

申请日：2024-05-11

申请人： STRYKER CORPORATION ,  STRYKER EUROPEAN OPERATIONS LIMITED

发明人： Clay W. Northrop ,  Aleksandr Leynov ,  Siddharth Loganathan ,  Danny Lai ,  Jonathan Gibbs ,  Samit Mustafa

IPC分类号： A61F2/95 ,  A61F2/966

CPC分类号： A61F2/95 ,  A61F2/9661 ,  A61F2002/9511

摘要： A delivery system for deploying a medical implant includes a delivery wire assembly disposed within a delivery catheter lumen, the assembly having an implant loading region configured for seating the implant when the assembly is constrained within the delivery catheter lumen and the implant is in a compressed configuration, the assembly further including an implant distal protection having a central portion coupled to the assembly, distal of the implant loading region, and a peripheral portion extending proximally from the central portion to at least partially cover a distal end portion of the implant when the assembly, implant and distal protection are constrained within the catheter lumen, wherein the peripheral portion remains extending in the proximal direction when the implant assumes an expanded configuration after being released from the catheter lumen, and the peripheral portion of the distal protection comprises a plurality of stems, each comprising a respective petal-like member.

公开(公告)号：US12076257B2

公开(公告)日：2024-09-03

申请号：US15947691

申请日：2018-04-06

申请人： ReFlow Medical, Inc.

发明人： Teodoro S. Jimenez ,  John Fulkerson ,  Isa Rizk ,  Jihad Ali Mustapha

IPC分类号： A61F2/92 ,  A61F2/848 ,  A61F2/90 ,  A61F2/966 ,  A61L31/16 ,  A61F2/95 ,  A61F2/958

CPC分类号： A61F2/92 ,  A61F2/848 ,  A61F2/90 ,  A61F2/966 ,  A61L31/16 ,  A61F2002/8483 ,  A61F2002/9528 ,  A61F2002/9534 ,  A61F2/958 ,  A61F2220/0016 ,  A61F2250/0067 ,  A61F2250/0098 ,  A61L2300/416

摘要： Delivery systems for expandable elements, such as stents or scaffolds having spikes, flails, or other protruding features for delivering drugs and/or penetrating target tissue within a human patient and associated methods for using such systems. The delivery systems can be configured to deliver and position expandable structures within a body lumen (e.g., vessel). In addition, these delivery systems can also be configured to deploy and expand the expandable structures in the body lumen. The delivery systems can further be configured to engage with the expanded structure and collapse the structure for removal from the body lumen. The delivery systems can be configured to deliver another expandable structure or the same expandable structure to another body lumen, or the same body lumen, in a single procedure or during a plurality of procedures.

公开(公告)号：US20240289953A1

公开(公告)日：2024-08-29

申请号：US18571790

申请日：2022-06-23

申请人： KONINKLIJKE PHILIPS N.V.

发明人： TOBIAS WISSEL

IPC分类号： G06T7/00 ,  A61F2/90 ,  A61F2/95 ,  G06T7/60

CPC分类号： G06T7/0012 ,  A61F2/90 ,  A61F2/95 ,  G06T7/60 ,  G06T2207/10116 ,  G06T2207/30101

摘要： A system (100) for identifying deformations of a deployed stent, is provided. The system includes one or more processors (110) configured to: receive (SI 10) X-ray image data representing one or more X-ray images (120) of a deployed stent (130) within a lumen (140), the stent including a plurality of stent struts (150): analyse (S120) the X-ray image data to determine a distribution of the stent struts (150) along an axis (160) of the lumen (140); and identify (S130) one or more longitudinally-deformed portions (170, 180) of the stent based on a density of the determined distribution of the stent struts (150) along the axis (160) of the lumen (140).

公开(公告)号：US12070541B2

公开(公告)日：2024-08-27

申请号：US18323077

申请日：2023-05-24

申请人： Orth Consulting, LLC

发明人： Donald S. Orth ,  Roger W. Orth

IPC分类号： A61M1/34 ,  A61F2/01 ,  A61F2/95 ,  A61K8/66 ,  A61M1/14 ,  A61M1/16 ,  A61M1/26 ,  A61M1/36 ,  B01D63/02 ,  B01D63/06 ,  B01D69/04 ,  B01D69/08 ,  B01J31/00 ,  C07K16/00 ,  C07K16/38 ,  C07K16/40 ,  C12N9/22 ,  C12N11/00 ,  C12N11/04 ,  C12N11/06 ,  C12N11/14 ,  C12N11/16

CPC分类号： A61M1/3489 ,  A61F2/01 ,  A61F2/95 ,  A61K8/66 ,  A61M1/15632 ,  A61M1/1621 ,  A61M1/1678 ,  A61M1/267 ,  A61M1/36 ,  A61M1/3601 ,  A61M1/3618 ,  A61M1/3621 ,  A61M1/3679 ,  A61M1/3687 ,  A61M1/3689 ,  B01D63/02 ,  B01D63/06 ,  B01D69/04 ,  B01D69/043 ,  B01D69/08 ,  B01J31/00 ,  B01J31/003 ,  C07K16/00 ,  C07K16/38 ,  C07K16/40 ,  C12N9/22 ,  C12N11/00 ,  C12N11/04 ,  C12N11/06 ,  C12N11/14 ,  C12N11/16 ,  A61M2202/0445 ,  A61M2205/3303 ,  A61M2205/3368

摘要： A blood treatment method includes the steps of inducing flow of a patient's blood through a blood treatment device inlet and outlet in fluid connection to the circulatory system of the patient. Metastatic deoxyribonucleic acid (DNA) contained within patient blood is destroyed by passing a patient's blood over a bioreactor surface having attached or immobilized deoxyribonuclease 1 (DNase 1) enzyme. The blood treatment device which consists of a bioreactor containing immobilized DNase 1, enables continuous treatment of a patient's blood and increases the effective concentration of DNase 1 in a patient's bloodstream to convert metastasizing cancer DNA in blood into non-oncogenic nucleotide fragments in vivo without adding any chemicals to the blood of the patient.